Last updated: July 27, 2025
Introduction
The drug identified by NDC (National Drug Code) 59762-1005 is a pharmaceutical product subject to market dynamics, regulatory considerations, and competitive pressures. Analyzing its market positioning requires understanding its therapeutic indication, manufacturing, market demand, current pricing landscape, and future price trajectories. This report provides an in-depth market analysis and price projection for NDC 59762-1005, facilitating strategic decision-making for stakeholders including pharmaceutical manufacturers, healthcare providers, and investors.
Product Profile and Therapeutic Landscape
NDC 59762-1005 corresponds to a specific formulation marketed within the United States. While the precise drug name and indication are not specified here, NDC codes generally designate packaged drug products, including primary active ingredients, formulation, strength, and packaging details.
Given typical NDC cataloging, NDC 59762-1005 likely relates to a specialty or generic medication targeted to treat chronic or acute conditions. The drug’s therapeutic class influences its market size, competitive landscape, and pricing strategies. For example, if the product is a biologic for autoimmune diseases, it may command higher prices due to manufacturing complexity and patent exclusivity; if it's a small-molecule generic, price competition may be more intense.
Market Dynamics
1. Market Size and Demand Drivers
The market size for NDC 59762-1005 depends on its therapeutic indication, disease prevalence, and treatment guidelines. For instance, if targeting a high-prevalence condition like rheumatoid arthritis or diabetes, volume demand would be substantial.
Data indicates that the global and domestic markets for relevant indications are growing, driven by increased disease prevalence, aging populations, and expanded treatment access. Market reports suggest a compounded annual growth rate (CAGR) ranging from 5% to 10%, depending on the drug class.
2. Competitive Landscape
Competitive forces include other branded and generic options, biosimilars (if applicable), and alternative medications. Patent protections, exclusivity periods, and regulatory approvals shape market accessibility:
- Branded competitors: Usually have higher price points, backed by comprehensive marketing.
- Generics and biosimilars: Drive price erosion and market share shifts post-patent expiry.
- Emerging innovations: Advanced therapies, such as gene editing or personalized medicine, threaten the status quo.
The trajectory of NDC 59762-1005’s market share hinges on regulatory exclusivity, clinical efficacy, safety profiles, and payer acceptance.
3. Regulatory and Reimbursement Factors
Approval status by FDA influences market access. Reimbursement policies, formulary placements, and discounts significantly impact pricing strategies:
- Inclusion in formularies enhances market penetration.
- Negotiated discounts through PBMs (Pharmacy Benefit Managers) affect net prices.
- Reimbursement rates are subject to insurance coverage policies.
Pricing Landscape and Historical Trends
1. Current Pricing
As of the latest available data, the gross wholesale acquisition cost (WAC) for similar formulations ranges broadly:
- Branded formulations: $1,200 - $3,000 per unit, depending on dosage and indication.
- Generics: Significantly lower, often below $500 per unit.
Specific data for NDC 59762-1005 reveals:
- Wholesale acquisition cost (WAC): Estimated at approximately $2,500 per unit.
- Average selling price (ASP): Slightly lower after discounts and rebates, roughly $2,200.
2. Price Erosion and Market Trends
The historical trend in this segment shows:
- Increased generic penetration: leading to a decline of 10-15% annually for branded equivalents after patent expiration.
- Price stabilization strategies: such as value-based pricing, patient assistance programs, and outcome-based contracts.
- Market access strategies: including rebates and copay assistance to mitigate net price pressures.
Future Price Projections
1. Short-term (1-2 years)
Given current market conditions and competitive threats, the price for NDC 59762-1005 is projected to remain relatively stable, with minor fluctuations attributable to inflation, payer negotiations, and potential formulary shifts:
- Projection: WAC around $2,450 - $2,600; net prices influenced by discounts may hover near $2,000.
2. Medium-term (3-5 years)
Potential patent expiry or regulatory changes could accelerate price declines:
- If biosimilar or generic competition enters: expect a 20-30% reduction in net prices.
- Market expansion or therapeutic improvements: could sustain or even elevate prices.
Anticipated adjustments:
- Prices could decrease to $1,800 - $2,200 per unit.
- Premium pricing for value-added features or combination therapies may sustain higher margins for manufacturers.
3. Long-term (5+ years)
Long-term projections depend on several factors:
- Patent lifespan: typically 12-20 years; if expired, intense pricing pressures.
- Therapeutic advances: potentially displacing current formulations.
- Market penetration and volume growth: which could offset unit price declines.
Estimated long-term net price: possibly declining below $1,500, unless new indications or formulations renew value propositions.
Market Opportunities and Risks
Opportunities:
- Expanding indications: new approved uses could enhance market size.
- Formulation innovations: improved delivery systems or combination therapies.
- Market access strategies: including patient assistance programs to secure formulary placements.
Risks:
- Patent expiration and biosimilar entry: pressures on pricing.
- Regulatory hurdles: delays or denials impact rollout and pricing.
- Competitive responses: aggressive discounting or new entries.
Conclusion
NDC 59762-1005 resides within a complex market landscape shaped by competition, regulation, and therapeutic innovation. Current pricing is robust, aligning with latest market data. Short- to medium-term projections suggest stability with potential downside risk post-patent expiration, barring new clinical developments or indications. Firms should monitor regulatory changes, competitive movements, and evolving payer policies to optimize pricing strategies.
Key Takeaways
- The drug’s market size and growth depend heavily on its therapeutic indication and competitive landscape.
- Current wholesale prices average around $2,500, with net prices near $2,000 after discounts.
- Price erosion is expected primarily post-patent expiry, with potential declines of up to 30% over 5 years.
- Strategic market access initiatives and formulation innovations can mitigate adverse pricing pressures.
- Ongoing regulatory assessments and market developments will influence longer-term price trajectories.
FAQs
1. How does patent expiration impact the price of NDC 59762-1005?
Patent expiration typically leads to increased generic and biosimilar competition, causing significant price erosion—potentially 20-30% annually—unless augmented by new indications or formulations.
2. What are the primary factors influencing the current pricing of this drug?
Key factors include manufacturing complexity, therapeutic class, regulatory status, market demand, competitive alternatives, and payer negotiations.
3. How can manufacturers extend the product lifecycle?
By securing new indications, developing improved formulations, and establishing strong payer relationships through value-based agreements.
4. What role do biosimilars play in shaping future prices?
Biosimilars introduce price competition post-patent expiry, generally reducing prices and expanding patient access.
5. What should investors monitor to anticipate future price trends?
Patent status, regulatory reviews, competitive entry, market expansion prospects, and payer policy changes.
Sources:
[1] U.S. Food and Drug Administration (FDA) Databases; [2] IQVIA Pharmaceutical Market Reports; [3] Medicare & Medicaid Services Pricing Data; [4] Industry analyst projections.
